OpGen Inc (LTS:0A8L)
$ 5.087 0 (0%) Market Cap: 4.87 Mil Enterprise Value: 17.13 Mil PE Ratio: 0 PB Ratio: 1.44 GF Score: 34/100

Q4 2021 OpGen Inc Earnings Call Transcript

Mar 29, 2022 / 08:30PM GMT
Release Date Price: $161.7 (-5.99%)
Operator

Welcome to the OpGen Fourth Quarter and Full Year 2021 Earnings Call and Business Update. Today, OpGen management will provide an update on the company's current business and outlook for the future. (Operator Instructions) As a reminder, this conference call is being recorded today, March 29, 2022.

At this time, we would like to turn the call over to Joe Green, OpGen's IR representative to provide the opening remarks.

Joe Green

Thank you, operator, and good afternoon. Before we begin, some important information. Any comments made by management during this conference call may contain forward-looking statements regarding the operations of and future results of OpGen, including its subsidiaries, Curetis and Ares Genetics. I encourage you to review OpGen's filings with the Securities and Exchange Commission, including, without limitation, the company's most recent Form 10-K for fiscal year 2021 that will be filed with the SEC, which will identify the specific factors that may cause actual results or events to differ materially from those described in the forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot